References
- Drug Diversion in the Medicaid Program State Strategies for Reducing Prescription Drug Diversion in Medicaid. In: Center for Medicare and Medicaid Services; 2012
- Katz NP, Birnbaum H, Brennen MJ, Freedman JD, Gilmore GP, Jay D, Kenna GA, et al. Prescription opioid abuse: challenges and opportunities for payers. Am J Managed Care 2013;19:295–302
- McAdam-Marx C, Roland CL, Cleveland J, Oderda GM. Costs of opioid abuse and misuse determined from a Medicaid database. J Pain Palliative Care Pharmacother 2010;24:5–18
- Chinn FJ. Medicaid recipient lock-in program – Hawaii’s experience in six years. Hawaii Med J 1985;44:9–18
- Singleton TE. Missouri’s Lock-In:control of recipient misutilization. J Medicaid Manage 1977;1:10–17
- Blake S. The effect of the Louisiana Medicaid lock-in on prescription drug utilization and expenditures. Drug Benefit Trends 1999;11:45–55
- Keast SL. Lock-In program evaluation. Oklahoma City, OK: Oklahoma Health Care Authority; 2008
- Prescription Monitoring Program (PMP). Oklahoma Bureau of Narcotis and Dangerous Drugs Control. Available from: http://www.ok.gov/obndd/Prescription_Monitoring_Program/. [last accessed 25 Feb 2014]
- Oklahoma State Bureau of Narcotics and Dangerous Drugs Control. In: Rules OSOoA, ed. 475:45-1-5. Oklahoma; 2011
- Annual Review of Narcotic Analgesics – Fiscal Year 2009: Oklahoma Health Care Authority; 2009
- Oklahoma Medicaid Drug Utilization Review Annual Report – Federal Fiscal Year 2010: Okahoma Health Care Authority; 2011
- Oklahoma Medicaid Drug Utilization Review Annual Report – Federal Fiscal Year 2011: Oklahoma Health Care Authority; 2012
- Policy impact: prescription drug overdose state rates; Center for Disease Control and Prevention, 2011. Available from: http://www.cdc.gov/HomeandRecreationalSafety/rxbrief/states.html [last accessed 15 Aug 2013]
- Nguyen C, Wendling T, Brown S. Unintentional poisoning deaths in Oklahoma, 2007–2011. Oklahoma City, OK: Injury Prevention Service Oklahoma State Department of Health; 2013
- Massatti R, Beeghly C, Hall O, Kariisa M, Potts L. Increasing heroin overdoses in Ohio: understanding the issue. Columbus, OH: Ohio Department of Mental Health and Addiction Services; 2014
- Independent Review of the SoonerCare Pharmacy Benefit and Management. Oklahoma City, OK: Mercer Health and Benefits LLC; 14 April 2014
- CDC Expert Panel Meeting Report. Patient Review and Restriction Programs Lessons learned from state Medicaid programs: Centers for Disease Control and Prevention (CDC) December 9, 2013
- Melnikow J, Yang Z, Soulsby M, Ritley D, Kizer K. Approaches to Drug Overdose Prevention Analytical Tool (ADOPT): evaluating cost and health impacts of a Medicaid Patient Review & Restriction Program: Center for Healthcare Policy and Research; Dec 2012
- Oklahoma Health Care Authority. Internal Report: Utilization Review of Narcotic Prescribing. 2012
- Manchikanti L, Fellows B, Damron KS, Pampati V, McManus CD. Prevalence of illicit drug use among individuals with chronic pain in the Commonwealth of Kentucky: an evaluation of patterns and trends. J Kentucky Med Assoc 2005;103:55–62
- Soumerai SB. Benefits and risks of increasing restrictions on access to costly drugs in Medicaid. Health Affairs 2004;23:135–146
- RFA-CE-14-002 Research to prevent prescription drug overdoses. Centers for Disease Control and Prevention – Department of Health and Human Services. Available from:http://www.grants.gov/web/grants/view-opportunity.html?oppId=249388 [last accessed 27 Feb 2014]